Ebola as a case study for the patent landscape of medical countermeasures for emerging infectious diseases
- 13 July 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 39 (7), 799-807
- https://doi.org/10.1038/s41587-021-00970-z
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014–2016 Ebola epidemic in West AfricaCurrent Opinion in Virology, 2016
- The role of rapid diagnostics in managing Ebola epidemicsNature, 2015
- WHO's next? Changing authority in global health governance after EbolaInternational Affairs, 2015
- Ebola Virus Disease in the Democratic Republic of CongoThe New England Journal of Medicine, 2014
- Potential for large outbreaks of Ebola virus diseaseEpidemics, 2014
- The network of innovators in Jena: An application of social network analysisResearch Policy, 2006
- Historical analysis of the Ebola virus: prospective implications for primary care nursing today.1998
- VIRAL HÆMORRHAGIC FEVER IN SOUTHERN SUDAN AND NORTHERN ZAIRE: Preliminary Studies on the Aetiological AgentThe Lancet, 1977
- ISOLATION AND PARTIAL CHARACTERISATION OF A NEW VIRUS CAUSING ACUTE HÆMORRHAGIC FEVER IN ZAIREThe Lancet, 1977
- ISOLATION OF MARBURG-LIKE VIRUS FROM A CASE OF HÆMORRHAGIC FEVER IN ZAIREThe Lancet, 1977